Simulations Plus Appoints Former FDA Official Lisa LaVange to its Board
Simulations Plus, a provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development, announced the appointment of Lisa LaVange to its board.
LaVange is a professor and associate chair of the Department of Biostatistics in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill. She currently is principal investigator of the coordinating centers for two large and complex trial networks. From 2011 to 2017, she served as director of the Office of Biostatistics in the Center for Drug Evaluation and Research at the U.S. Food and Drug Administration.
“For more than 35 years, I have worked with commercial organizations, academic researchers, and government regulators in areas of statistical research and methodologies, with a particular focus on biotechnology,” says LaVange. “Throughout most of that time, Simulations Plus has been a leader in the advancement of sophisticated modeling and simulation technology in this sector. I am honored and excited to join the board of directors, and I look forward to helping Simulations Plus continue its growth.”
LaVange also worked for Quintiles, Inc., most recently as vice president of Biostatistics and also served as vice president, biostatistics and data management, for Inspire Pharmaceuticals Inc.
“LaVange was selected after the most exhaustive search for a new independent director in our company’s history, and we could not be more thrilled to add a leader with her broad and noteworthy expertise to our board,” says Walt Woltosz, founder and chairman of the board. “Her tenures at Quintiles and Inspire provide highly relevant experience to our board, enabling her to easily put herself in the position of our customers. In addition, the board and management will benefit from her experience with the FDA, as well as her deep academic background.”
~ Barbara Wenger